These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23654124)

  • 21. Nicotine vaccines to assist with smoking cessation: current status of research.
    Raupach T; Hoogsteder PH; Onno van Schayck CP
    Drugs; 2012 Mar; 72(4):e1-16. PubMed ID: 22356293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical development of a vaccine 'against smoking'.
    Cerny EH; Lévy R; Mauel J; Mpandi M; Mutter M; Henzelin-Nkubana C; Patiny L; Tuchscherer G; Cerny T
    Onkologie; 2002 Oct; 25(5):406-11. PubMed ID: 12415193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment and prevention of tobacco addiction. Antinicotinic vaccine].
    Fernández PL
    An R Acad Nac Med (Madr); 2012; 129(1):295-304; discussion 304-6. PubMed ID: 24294730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeutic.
    Hatsukami DK; Jorenby DE; Gonzales D; Rigotti NA; Glover ED; Oncken CA; Tashkin DP; Reus VI; Akhavain RC; Fahim RE; Kessler PD; Niknian M; Kalnik MW; Rennard SI
    Clin Pharmacol Ther; 2011 Mar; 89(3):392-9. PubMed ID: 21270788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trial watch: Xenova's TA-NIC vaccine shows promise.
    Expert Rev Vaccines; 2004 Aug; 3(4):386. PubMed ID: 15270640
    [No Abstract]   [Full Text] [Related]  

  • 26. Vaccination against nicotine: an emerging therapy for tobacco dependence.
    Maurer P; Bachmann MF
    Expert Opin Investig Drugs; 2007 Nov; 16(11):1775-83. PubMed ID: 17970637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccines in trials for nicotine cessation therapy.
    Bennett L
    JAAPA; 2013 Sep; 26(9):55-6. PubMed ID: 24069675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cigarette smoking and nicotine addiction.
    Benowitz NL
    Med Clin North Am; 1992 Mar; 76(2):415-37. PubMed ID: 1548969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prospects for immunotherapy in smoking cessation.
    Hall W
    Lancet; 2002 Oct; 360(9339):1089-91. PubMed ID: 12384004
    [No Abstract]   [Full Text] [Related]  

  • 30. Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.
    Rosenberg JB; De BP; Hicks MJ; Janda KD; Kaminsky SM; Worgall S; Crystal RG
    Hum Gene Ther; 2013 Jun; 24(6):595-603. PubMed ID: 23611296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A vaccine for nicotine dependence: targeting the drug rather than the brain.
    Pentel P; Malin D
    Respiration; 2002; 69(3):193-7. PubMed ID: 12097758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical evaluation of a nicotine vaccine within a self-administration behavioral model.
    Moreno AY; Azar MR; Warren NA; Dickerson TJ; Koob GF; Janda KD
    Mol Pharm; 2010 Apr; 7(2):431-41. PubMed ID: 20104903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of passive immunization with nicotine-specific antibodies on the acute and chronic distribution of nicotine to brain in rats.
    Pentel PR; Dufek MB; Roiko SA; Lesage MG; Keyler DE
    J Pharmacol Exp Ther; 2006 May; 317(2):660-6. PubMed ID: 16407464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing the Immune Response of a Nicotine Vaccine with Synthetic Small "Non-Natural" Peptides.
    Le HT; Fraleigh NL; Lewicky JD; Boudreau J; Dolinar P; Bhardwaj N; Diaz-Mitoma F; Montaut S; Fallahi S; Martel AL
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32178357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats.
    LeSage MG; Keyler DE; Hieda Y; Collins G; Burroughs D; Le C; Pentel PR
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):409-16. PubMed ID: 15991003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in pharmacotherapy for tobacco dependence.
    Foulds J; Burke M; Steinberg M; Williams JM; Ziedonis DM
    Expert Opin Emerg Drugs; 2004 May; 9(1):39-53. PubMed ID: 15155135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic vaccines against tobacco addiction.
    Fahim RE; Kessler PD; Kalnik MW
    Expert Rev Vaccines; 2013 Mar; 12(3):333-42. PubMed ID: 23496672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nicotine substitution per inhaler. The "cigarette" against addiction].
    Haustein KO
    MMW Fortschr Med; 2002 Jan; 144(5):35-6. PubMed ID: 11883033
    [No Abstract]   [Full Text] [Related]  

  • 39. Negatively Charged Carbon Nanohorn Supported Cationic Liposome Nanoparticles: A Novel Delivery Vehicle for Anti-Nicotine Vaccine.
    Zheng H; Hu Y; Huang W; de Villiers S; Pentel P; Zhang J; Dorn H; Ehrich M; Zhang C
    J Biomed Nanotechnol; 2015 Dec; 11(12):2197-210. PubMed ID: 26510313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing the protective effects of a conformationally constrained nicotine vaccine.
    Moreno AY; Azar MR; Koob GF; Janda KD
    Vaccine; 2012 Oct; 30(47):6665-70. PubMed ID: 22963803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.